Vita Coco director receives 1,530 share RSU award

Vita Coco Company, Inc. director John Zupo reported an equity compensation grant and his current holdings.

Rhea-AI Filing Summary

Vita Coco Company, Inc. director John Zupo reported an equity compensation grant and his current holdings. He received 1,530 deferred restricted stock units (RSUs), each representing one share of common stock, granted under the company’s 2021 Incentive Award Plan. These RSUs vest in full on the earlier of the day immediately preceding the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided he remains in continuous service, and will settle on June 3, 2031. Following this grant, he holds 13,692 shares of common stock directly. He also holds a fully vested, currently exercisable non-qualified stock option covering 20,675 shares of common stock at an exercise price of $10.178 per share, expiring on December 16, 2029.

Insider Trade Summary

Grant/Award: 1,530 shares

Grant/Award 2 txns

Insider Zupo John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,530	$75.18	$115K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 13,692 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 20,675 contracts (Direct)

Footnotes (2)

1. F1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.
2. F2. The stock option is fully vested and currently exercisable.

Key Figures

Deferred RSU grant: 1,530 units Shares owned after grant: 13,692 shares Option underlying shares: 20,675 shares +3 more

6 metrics

Deferred RSU grant 1,530 units Equity award reported on Form 4

Shares owned after grant 13,692 shares Direct common stock holdings following transaction

Option underlying shares 20,675 shares Non-qualified stock option for Vita Coco common stock

Option exercise price $10.178 per share Exercise price for non-qualified stock option

Option expiration December 16, 2029 Expiration date of non-qualified stock option

RSU settlement date June 3, 2031 Deferred RSUs settle into common shares on this date

Key Terms

Non-Qualified Stock Option (Right to Buy), deferred RSUs, 2021 Incentive Award Plan, vest in full, +1 more

5 terms

Non-Qualified Stock Option (Right to Buy) financial

"security_title: Non-Qualified Stock Option (Right to Buy)"

deferred RSUs financial

"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan"

2021 Incentive Award Plan financial

"deferred RSUs granted under the company's 2021 Incentive Award Plan"

vest in full financial

"which vest in full the earlier of (i) the day immediately preceding"

continuous service financial

"provided that the Reporting Person remains in continuous service on the applicable vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vita Coco (COCO) director John Zupo report on this Form 4?

John Zupo reported an equity compensation grant and updated holdings. The filing shows a grant of 1,530 deferred RSUs and discloses his direct common stock ownership and a fully vested stock option position that remains exercisable.

How many Vita Coco shares did John Zupo acquire in this Form 4?

He acquired 1,530 deferred restricted stock units (RSUs). Each deferred RSU represents the right to receive one share of Vita Coco common stock, subject to vesting and a deferred settlement date in 2031, rather than an immediate share issuance.

What are the vesting and settlement terms for John Zupo’s 1,530 Vita Coco RSUs?

The 1,530 deferred RSUs vest in full based on time and service. They vest on the earlier of the day immediately before the next Annual Stockholders Meeting after the grant date or the first anniversary, if he remains in continuous service, and settle on June 3, 2031.

How many Vita Coco common shares does John Zupo hold after this transaction?

After the transaction, John Zupo directly holds 13,692 common shares. This figure reflects his updated non-derivative ownership reported in the Form 4, separate from his deferred RSUs and stock options that may convert into additional shares later.

What stock options does John Zupo hold in Vita Coco after this filing?

He holds a fully vested non-qualified stock option for 20,675 shares. The option has an exercise price of $10.178 per share, is currently exercisable, and carries an expiration date of December 16, 2029, providing long-term leveraged exposure to the stock.

Is John Zupo’s Vita Coco Form 4 an open-market stock purchase?

No, the Form 4 reflects an equity grant, not an open-market buy. The 1,530 units are deferred RSUs granted as compensation under the 2021 Incentive Award Plan, with specific vesting and settlement terms rather than a cash purchase on the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zupo John

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		1,530(1)	A	$75.18	13,692	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	12/16/2029	Common Stock	20,675		20,675	D

Explanation of Responses:

1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

2. The stock option is fully vested and currently exercisable.

	/s/ Alison Klein, Attorney-in-Fact for John Zupo	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)